Meniscus; Degeneration Clinical Trial
Official title:
Comparison of the Effects of Different Telerehabilitation Methods on Pain, Functional Limitation, Muscle Strength, Balance, and Quality of Life in Patients With Meniscus Degeneration
Our study will include 60 patients diagnosed with meniscus degeneration in the Department of Physiotherapy and Rehabilitation of the Faculty of Health Sciences of Marmara University. Volunteers will be informed about the purpose of the study and the evaluations and treatments to be carried out, and their consent will be obtained by reading the 'Informed Volunteer Consent Form' and obtaining their signatures. The sample group and distribution will be determined as 30 asynchronous telerehabilitation groups and 30 synchronous telerehabilitation groups. Our study is a randomized controlled trial. Groups will be formed in a randomized manner and blinded study design will be used to evaluate outcome parameters. Patients beginning the rehabilitation program will be evaluated at the start of the study, at week 4, week 8, and week 16. Demographic information of the patients participating in the study will be obtained using the demographic data form. Visual Analogue Scale (VAS) for pain, WOMET index for functionality and quality of life, functionality with Lysholm Knee Scoring Scale and quality of life with Patient Generated Index (PGI) and Short Form-12 (SF-12) scales; Functional mobility Timed Up and Go Test (TUG), functional capacity 2 Minutes Walk Test (2 MWT), balance Balance Master, proprioception and muscle strength Isokinetic assessment device, lower extremity neuromuscular function level 30 sec Sit Up and 5 Sit & Go performance tests will be evaluated with Our study will investigate the comparison of the effects of asynchronous and synchronous telerehabilitation programs on pain, functional limitation, muscle strength and quality of life in patients with meniscal degeneration.
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | April 15, 2023 |
Est. primary completion date | December 27, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Pain less than or equal to 7 according to VAS - Individuals aged 18-65 - Patients with independent mobility Exclusion Criteria: - Patients who have undergone surgery in the last 1 year - Patients who have undergone total knee replacement or total hip replacement surgery - Patients with acute trauma in the last 1 year - Patients with uncontrolled chronic disease - Patients who have received physical therapy in the last 6 months - Patients who have received hyaluronic acid and corticosteroid injections in the last 6 months - Patients with a respiratory condition that interferes with walking will not be included. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Marmara University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The Lysholm score | The Lysholm score is a 100-point scoring system for examining a patient's knee-specific symptoms including mechanical locking, instability, pain, swelling, stair climbing, and squatting. | The The Lysholm score will be measured at baseline 2 minutes after pain assessment. | |
Primary | The Lysholm score | The Lysholm score is a 100-point scoring system for examining a patient's knee-specific symptoms including mechanical locking, instability, pain, swelling, stair climbing, and squatting. | The The Lysholm score will be measured at the end of intervention (8. week) 2 minutes after pain assessment. | |
Primary | Visual analogue scale (VAS) | Pain will be measured using a 10 cm visual analogue scale (VAS). The participants places a mark on the line that best represented their perception of pain at that instant. The VAS score will be measured in cm from the left hand end of the line to the mark. | The pain will be measured at baseline | |
Primary | Visual analogue scale (VAS) | Pain will be measured using a 10 cm visual analogue scale (VAS). The participants places a mark on the line that best represented their perception of pain at that instant. The VAS score will be measured in cm from the left hand end of the line to the mark. | The pain will be measured at the end of intervention (8. week). | |
Secondary | 12-Item Short Form Survey (SF-12) | The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality of life measure.
The SF-12 is a shortened version of it's predecessor, the SF-36, which itself evolved from the Medical Outcomes Study. The SF-12 was created to reduce the burden of response. The SF-12 uses the same eight domains as the SF-36: Limitations in physical activities because of health problems. Limitations in social activities because of physical or emotional problems Limitations in usual role activities because of physical health problems Bodily pain General mental health (psychological distress and well-being) Limitations in usual role activities because of emotional problems Vitality (energy and fatigue) General health perceptions |
The SF-12 will be measured at baseline 2 minutes after The Lysholm score assessment. | |
Secondary | 12-Item Short Form Survey (SF-12) | The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality of life measure.
The SF-12 is a shortened version of it's predecessor, the SF-36, which itself evolved from the Medical Outcomes Study. The SF-12 was created to reduce the burden of response. The SF-12 uses the same eight domains as the SF-36: Limitations in physical activities because of health problems. Limitations in social activities because of physical or emotional problems Limitations in usual role activities because of physical health problems Bodily pain General mental health (psychological distress and well-being) Limitations in usual role activities because of emotional problems Vitality (energy and fatigue) General health perceptions |
The SF-12 will be measured at the end of intervention (8. week) 2 minutes after The Lysholm score assessment. | |
Secondary | 30 Seconds Sit To Stand Test | The 30 Second Sit to Stand Test is also known as 30 second chair stand test ( 30CST), is for testing leg strength and endurance in older adults. The 30-Second Chair Test is administered using a folding chair without arms, with seat height of 17 inches (43.2 cm). The chair, with rubber tips on the legs, is placed against a wall to prevent it from moving.
The participant is seated in the middle of the chair, back straight; feet approximately a shoulder width apart and placed on the floor at an angle slightly back from the knees, with one foot slightly in front of the other to help maintain balance. Arms are crossed at the wrists and held against the chest. Have the patient practice a repetition or two before completing the test. The participant is encouraged to complete as many full stands as possible within 30 seconds. The participant is instructed to fully sit between each stand. |
The 30 Seconds Sit To Stand Test will be measured at baseline 2 minutes after SF-12 assessment. | |
Secondary | 30 Seconds Sit To Stand Test | The 30 Second Sit to Stand Test is also known as 30 second chair stand test ( 30CST), is for testing leg strength and endurance in older adults. The 30-Second Chair Test is administered using a folding chair without arms, with seat height of 17 inches (43.2 cm). The chair, with rubber tips on the legs, is placed against a wall to prevent it from moving.
The participant is seated in the middle of the chair, back straight; feet approximately a shoulder width apart and placed on the floor at an angle slightly back from the knees, with one foot slightly in front of the other to help maintain balance. Arms are crossed at the wrists and held against the chest. Have the patient practice a repetition or two before completing the test. The participant is encouraged to complete as many full stands as possible within 30 seconds. The participant is instructed to fully sit between each stand. |
The 30 Seconds Sit To Stand Test will be measured at the end of intervention (8. week) 2 minutes after SF-12 assessment. | |
Secondary | 2 Minute Walk Test | The Two/2 Minute Walk Test (2MWT) is a measure of self-paced walking ability and functional capacity.
The person is encouraged to walk as fast as they can, safely, without assistance for two minutes and the distance is measured. Start timing when the individual is instructed to "Go". Stop timing at 2 minutes. Assistive devices can be used but should be kept consistent and documented from test to test. If physical assistance is required to walk, the test should not be performed. The measuring wheel is helpful to determine the distance walked. The person should walk at the fastest speed possible. Rest breaks are allowed if needed. Before starting the test, the observer gives initial instructions. |
The 2 Minute Walk Test will be measured at baseline 5 minutes after 30 Seconds Sit To Stand Test assessment. | |
Secondary | 2 Minute Walk Test | The Two/2 Minute Walk Test (2MWT) is a measure of self-paced walking ability and functional capacity.
The person is encouraged to walk as fast as they can, safely, without assistance for two minutes and the distance is measured. Start timing when the individual is instructed to "Go". Stop timing at 2 minutes. Assistive devices can be used but should be kept consistent and documented from test to test. If physical assistance is required to walk, the test should not be performed. The measuring wheel is helpful to determine the distance walked. The person should walk at the fastest speed possible. Rest breaks are allowed if needed. Before starting the test, the observer gives initial instructions. |
The 2 Minute Walk Test will be measured at the end of intervention (8. week) 5 minutes after 30 Seconds Sit To Stand Test assessment. | |
Secondary | Quadriceps and Hamstring Muscle Strength | Isometric muscle strength of the Quadriceps Femoris and Hamstring muscle groups will be measured at 30º and 60º using the Biodex® System Pro3 (Biodex Corp. Shirley NY, USA) isokinetic test dynamometer. During the test, the back angle of the dynamometer seat is adjusted to 85° and the patients are asked to hold on to the bars next to the seat. The leg to be tested is fixed with the help of belts to prevent compensation of the pelvis and trunk. The test protocol was explained to the patients beforehand; They were instructed to apply force (30º and 60º angle) to the specified area of the device with as much effort as they could and not to allow the device to move their extremities. Before the isometric muscle strength test is performed on the isokinetic system, the patients were given 3 repetitive exercises. The dynamometric test was first performed with 3 repetitions at an angle of 30º, and then 3 repetitions at 60º. 15 seconds between tests, rest periods are given. | The Quadriceps and Hamstring Muscle Strength will be measured at baseline 15 minutes after 2 Minute Walk Test assessment. | |
Secondary | Quadriceps and Hamstring Muscle Strength | Isometric muscle strength of the Quadriceps Femoris and Hamstring muscle groups will be measured at 30º and 60º using the Biodex® System Pro3 (Biodex Corp. Shirley NY, USA) isokinetic test dynamometer. During the test, the back angle of the dynamometer seat is adjusted to 85° and the patients are asked to hold on to the bars next to the seat. The leg to be tested is fixed with the help of belts to prevent compensation of the pelvis and trunk. The test protocol was explained to the patients beforehand; They were instructed to apply force (30º and 60º angle) to the specified area of the device with as much effort as they could and not to allow the device to move their extremities. Before the isometric muscle strength test is performed on the isokinetic system, the patients were given 3 repetitive exercises. The dynamometric test was first performed with 3 repetitions at an angle of 30º, and then 3 repetitions at 60º. 15 seconds between tests, rest periods are given. | The Quadriceps and Hamstring Muscle Strength will be measured at the end of intervention (8. week) 15 minutes after 2 Minute Walk Test assessment. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05882591 -
Posteromedial Tibiofemoral Incongruence (PMTFI) Treatment
|
N/A | |
Completed |
NCT06308887 -
Comparison of Ultrasound-Guided Perimeniscal Steroid and 5% Dextrose Injections in Knee Osteoarthritis
|
Phase 4 | |
Recruiting |
NCT04972331 -
Degenerative Meniscus Without Osteoarthritis : Arthroscopic Partial Menisectomy Versus Platelet Rich Plasma (APM-PRP)
|
N/A | |
Enrolling by invitation |
NCT04641351 -
Corticosteroid Meniscectomy Randomized Trial
|
Phase 4 | |
Recruiting |
NCT05261360 -
Clinical Efficacy of Exosome in Degenerative Meniscal Injury
|
Phase 2 | |
Completed |
NCT05233839 -
Efficacy of Telerehabilitation in Patients With Degenerative Meniscal Injury
|
N/A | |
Recruiting |
NCT03953846 -
NUsurface Implant Registry
|
||
Completed |
NCT04837456 -
Metabolic Syndrome and Degenerate Meniscus Tears
|
N/A | |
Recruiting |
NCT05128851 -
High Tibial Osteotomy With/Without Arthroscopy.
|
N/A | |
Completed |
NCT01712191 -
Treatment of the Medial Meniscus With the NUsurface(R) Meniscus Implant
|
N/A |